Jul 12 |
Amgen’s Imdelltra BiTEs into SCLC treatment drought
|
Jul 12 |
This weight loss stock is the best alternative to Eli Lilly, Novo - SA Sentiment
|
Jul 9 |
Study Shows Lilly's (LLY) Obesity Drug More Effective Than NVO's
|
Jul 9 |
Amgen Inc. (AMGN): Hedge Funds Are Bullish on This Blue Chip Dividend Stock Now
|
Jul 9 |
7 Cheap Biotech Stocks With Major Upside Potential
|
Jul 8 |
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know
|
Jul 8 |
Beat the Market Like Zacks: Carvana, Adobe, Amgen in Focus
|
Jul 7 |
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
|
Jul 6 |
Amgen: Biotech Leader Riding High On Obesity Drug Euphoria (Downgrade)
|
Jul 5 |
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
|